VHI trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VHI achieves its forward estimates and maintains a stable P/E multiple of 4.6x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 19, 2026, Valhi, Inc. (VHI) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $452M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Sell, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, VHI trades at a trailing P/E of 31.5x and forward P/E of 4.6x. Analysts expect EPS to grow +584.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $54.24, with bear and bull scenarios of $34.17 and $71.46 respectively. Model confidence stands at 38/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
KROKronos Worldwide, Inc. | $869M | $7.55 | $8.50 | +12.6% | Hold | 18.9x | 7 |
HUNHuntsman Corporation | $1.6B | $9.03 | $11.11 | +23.0% | Hold | — | 33 |
CCThe Chemours Company | $1.8B | $12.09 | $18.89 | +56.2% | Hold | 14.1x | 20 |
NLNLI Holdings, Inc. | $373M | $7.64 | $6.00 | -21.5% | Sell | 8.8x | 1 |
COMPCompass, Inc. | $6.2B | $10.13 | $14.00 | +38.2% | Buy | 140.7x | 13 |
TROXTronox Holdings plc | $238M | $1.49 | $5.86 | +293.3% | Hold | — | 17 |
BCPCBalchem Corp | $5.4B | $168.73 | $212.50 | +25.9% | Buy | 30.8x | 10 |
IOSPInnospec Inc. | $1.9B | $78.86 | $110.00 | +39.5% | Hold | 16.0x | 9 |
RTXRTX Corporation | $266.1B | $197.45 | $232.18 | +17.6% | Buy | 25.7x | 26 |
LMTLockheed Martin Corporation | $133.4B | $578.19 | $638.22 | +10.4% | Buy | 18.9x | 37 |
Quick answers to the most common questions about buying VHI stock.
The consensus price target for VHI is $N/A, close to the current price of $15.98 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
VHI has a consensus rating of "Sell" based on 1 Wall Street analysts. The rating breakdown is leaning bearish, with 1 Sell/Strong Sell ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 4.6052x, VHI trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for VHI, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $71 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
VHI is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VHI stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Sell". Our proprietary valuation model produces a base case fair value of $54, with bear/bull scenarios of $34/$71.
Our quantitative valuation model calculates VHI's fair value at $54 (base case), with a bear case of $34 and bull case of $71. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 38/100.
VHI trades at a forward P/E ratio of 4.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
VHI appears fairly valued according to analysts, with a "Sell" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VHI analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $34-$71 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.